Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005550602
Fri, 14.10.2022
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures for the third quarter of 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable
Lübeck, October 14, 2022 – Dräger's net sales in the third quarter of 2022 [ … ]
Fri, 14.10.2022
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures for the third quarter of 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable
Lübeck, October 14, 2022 – Dräger's net sales in the third quarter of 2022 [ … ]
Thu, 29.09.2022
Drägerwerk AG & Co. KGaA
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
On September 26, 2022, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back som [ … ]
Thu, 29.09.2022
Drägerwerk AG & Co. KGaA
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
On September 26, 2022, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back som [ … ]
Thu, 28.07.2022
Drägerwerk AG & Co. KGaA
Dräger expects significant recovery in business development in the second half of 2022
Order intake in the first half of the year significantly above prior-year level and own expectations
Significant decline in net sales and earnings as expected
Full-year forecast confirmed
Lübeck—Drägerwerk AG & Co. KGaA has increased its order intake in th [ … ]
Thu, 28.07.2022
Drägerwerk AG & Co. KGaA
Dräger expects significant recovery in business development in the second half of 2022
Order intake in the first half of the year significantly above prior-year level and own expectations
Significant decline in net sales and earnings as expected
Full-year forecast confirmed
Lübeck—Drägerwerk AG & Co. KGaA has increased its order intake in th [ … ]
Thu, 14.07.2022
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior-year level despite strong order development – full-year guidance confirmed due to expected business recovery in the second half of the year
Lübeck, July 14, 2022 – Dräger's net s [ … ]
Thu, 14.07.2022
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior-year level despite strong order development – full-year guidance confirmed due to expected business recovery in the second half of the year
Lübeck, July 14, 2022 – Dräger's net s [ … ]
Wed, 13.04.2022
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Dräger releases preliminary figures for the first quarter of 2022 - Increasing difficulties in the supply of electronic components make the lower end of the full-year guidance likely
Lübeck, April 13, 2022 - Based on preliminary calculations, Dräger's net sales [ … ]
Thu, 25.11.2021
Drägerwerk AG & Co. KGaA
Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
Purchase of own shares - final notice
In the period 2 November 2021 to 24 November 2021 (inclusive) a total of 89,308 preferred shares were bought back within the framework of the share buyback of Drägerwe [ … ]